vcfirmsdirectory.com

Venture capital · Early stage · Est. 1992

MPM BioImpact

Boston-based biotech investment firm that builds and funds drug-development companies, investing in both private and public markets. It pairs venture-style company creation with impact-focused public equity funds.

BostonRegistered · Boston
New investments · 12 months
Fund vehiclesPublic
14
14 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: mpmbioimpact.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round MPM BioImpact joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is MPM BioImpact right for your round?

Is MPM BioImpact a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
14
14 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ONCOLOGY IMPACT FUND 2, L.P.US private fund · Active · Cayman Islands · $1B gross assets · filed 28 Apr 2026
UBS ONCOLOGY IMPACT FUND L.P.US private fund · Active · Cayman Islands · $570.5M gross assets · filed 28 Apr 2026
MPM BIOVENTURES 2018, L.P.US private fund · Active · United States · $483.2M gross assets · filed 28 Apr 2026
MPM BIOVENTURES 2022, L.P.US private fund · Active · United States · $350.7M gross assets · filed 28 Apr 2026
BIOIMPACT EQUITIES FUND, LPUS private fund · Active · United States · $312.3M gross assets · filed 28 Apr 2026
MPM BIOIMPACT INNOVATIONS EQUITIES MASTER, LPUS private fund · Active · United States · $253.9M gross assets · filed 28 Apr 2026
NEW TECHNOLOGIES AND VIROLOGY FUND, L.P.US private fund · Active · Cayman Islands · $140.2M gross assets · filed 28 Apr 2026
MPM ONCOLOGY INNOVATIONS FUND L.P.US private fund · Active · United States · $130.9M gross assets · filed 28 Apr 2026
BIOIMPACT EQUITIES MASTER FUND, LPUS private fund · Active · Cayman Islands · $90.9M gross assets · filed 28 Apr 2026
MPM BIOVENTURES 2014, L.P.US private fund · Active · United States · $72.4M gross assets · filed 28 Apr 2026
MPM BIOVENTURES 2018 (B), L.P.US private fund · Active · United States · $24.8M gross assets · filed 28 Apr 2026
MPM ASSET MANAGEMENT INVESTORS BV2018 LLCUS private fund · Active · United States · $10.5M gross assets · filed 28 Apr 2026
2 more fund vehiclesSEC adviser filings
Deployed (new cheques)
Next fund expected

Latest investments

Rounds MPM BioImpact joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round MPM BioImpact joined

Round sizes, MPM BioImpact’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

AktisArialysAshiBioAstronauTxCrossbow TherapeuticsCullinan OncologyDyne TherapeuticselevatebioEntrada Therapeutics, Inc.Fableand 12 more

Portfolio and exits

Every company MPM BioImpact backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where MPM BioImpact puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet MPM BioImpact

Events where MPM BioImpact’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet MPM BioImpact’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

28 Apr 2026Fund filingForm ADV filed by MPM BIOIMPACT: 14 private funds, $3.5B in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

MPM BioImpact is based in Boston, United States.

In 1992.

14 fund vehicles are on public registers (SEC adviser filings), including ONCOLOGY IMPACT FUND 2, L.P., UBS ONCOLOGY IMPACT FUND L.P. and MPM BIOVENTURES 2018, L.P.

Stages: Seed. Sectors: Biotech, Life sciences. From the firm’s own website.

The firm builds and backs biotech companies across the full drug development process, from seed to follow-on, aiming to turn scientific breakthroughs into medicines. Entrepreneur Partners with deep domain and regulatory expertise help create and lead portfolio companies, with an impact-oriented approach. From the firm’s own website.

MPM BioImpact lists 22 portfolio companies on its website, including Aktis, Arialys, AshiBio, AstronauTx and Crossbow Therapeutics.

Firms whose websites list some of the same companies include Agent Capital, Atlas Venture and Catalio Capital Management.

Know before MPM BioImpact’s next round is announced.

PRO tracks MPM BioImpact’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

MPM BioImpactGet MPM BioImpact’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.